Business Standard

Tuesday, December 24, 2024 | 10:15 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Drug firm Lupin names Claus Jepsen as President Global specialty business

Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases

Claus Jepsen

Claus Jepsen

Press Trust of India New Delhi

Listen to This Article

Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.

Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.

"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 21 2024 | 11:52 PM IST

Explore News